1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Withdrawal from alpha1 antitrypsin replacement therapy: new trials by email Literature Review of Withdrawal from alpha1 antitrypsin replacement therapy trials Research Report on Withdrawal from alpha1 antitrypsin replacement therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency Aspirin, Placebo, Withdrawal from alpha1 antitrypsin replacement therapy - Alpha-1 Antitrypsin Deficiency, Emphysema | Phase 2 | Completed | Columbia University | 15 | 2017-01-01 | 2021-02-17 |
Emphysema (1) · Pulmonary Disease, Chronic Obstructive (1) · alpha 1-Antitrypsin Deficiency (1)
United States (1)
Carrie Aaron, MD (1)